Pharmacy - Chemotherapy/Oncology News & Articles

101 Multifunctional superparamagnetic iron oxide nanoparticles: Promising tools in cancer theranostics Cancer Letters, June 12, 2013    Review Article

102 miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT Oncogene, June 12, 2013    Clinical Article

103 All-trans retinoic acid and late relapses in acute promyelocytic leukemia: Very long-term follow-up of the North American Intergroup Study I0129 Leukemia Research, June 12, 2013    Clinical Article

104 Costs of trastuzumab in combination with chemotherapy for HER2-positive advanced gastric or gastroesophageal junction cancer: does one Analysis fit all? Full Text Translational Gastrointestinal Cancer, June 11, 2013    Review Article

105 Timing of surgery after long-course neoadjuvant chemoradiotherapy for rectal cancer: a systematic review of the literature Diseases of the Colon and Rectum, June 11, 2013    Evidence Based Medicine    Review Article

106 Mitomycin-c and capecitabine (MIXE) as salvage treatment in patients with refractory metastatic colorectal cancer: a retrospective study Anticancer Research, June 11, 2013    Clinical Article

107 Significant efficacy of 2-chlorodeoxyadenosine{+/-} rituximab in the treatment of splenic marginal zone lymphoma (SMZL): extended follow-up Annals of Oncology, June 11, 2013    Clinical Article

108 Eradication of breast cancer with bone metastasis by autologous formalin-fixed tumor vaccine (AFTV) combined with palliative radiation therapy and adjuvant chemotherapy: a case report Full Text World Journal of Surgical Oncology, June 11, 2013

109 Comparison of 7-day azacitidine and 5-day decitabine for treating myelodysplastic syndrome Annals of Hematology, June 11, 2013    Clinical Article

110 First line treatment with rituximab- Hyper-CVAD alternating with rituximab- Methotrexate- Cytarabine and followed by consolidation with 90Y-Ibritumomab-Tiuxetan in patients with mantle cell lymphoma. Results of a phase 2 pilot multicenter trial from the GELTAMO group. Full Text Haematologica, June 11, 2013    Clinical Article

111 A pilot study of salvage irinotecan monotherapy for advanced biliary tract cancer Anticancer Research, June 11, 2013    Clinical Article

112 Hedgehog targeting by cyclopamine suppresses head and neck squamous cell carcinoma and enhances chemotherapeutic effects Anticancer Research, June 11, 2013    Clinical Article

113 Unexpected alteration of β-catenin and c-KIT expression by 5-fu and docetaxel in p16-positive squamous cell carcinoma compared to HPV-negative HNSCC cells Anticancer Research, June 11, 2013    Clinical Article

114 Understanding the functions of tumor stroma in resistance to ionizing radiation: Emerging targets for pharmacological modulation Drug Resistance Updates, June 11, 2013    Review Article

115 Pulmonary collision tumor consisting of adenocarcinoma and typical carcinoid-a case report and review of literature American Journal of Therapeutics, June 11, 2013

116 Journey of the ALK-inhibitor CH5424802 to phase II clinical trial Full Text Archives of Pharmacal Research, June 11, 2013    Clinical Article

117 Pharmacokinetics and tissue distribution of spray-dried carboplatin microspheres: lung targeting via intravenous route Full Text Archives of Pharmacal Research, June 11, 2013    Clinical Article

118 Dasatinib: a novel therapy for breast cancer? Expert Opinion on Investigational Drugs, June 10, 2013    Review Article

119 Statins are associated with reduced risk of gastric cancer: A meta-analysis European Journal of Clinical Pharmacology, June 10, 2013    Evidence Based Medicine    Review Article

120 Phase ii study of a triple combination of oral vinorelbine, capecitabine and trastuzumab as first-line treatment in HER2-positive metastatic breast cancer Anticancer Research, June 10, 2013    Clinical Article

1 All-oral combination of vinorelbine and capecitabine as first-line treatment in HER2/Neu-negative metastatic breast cancer Cancer Chemotherapy and Pharmacology, March 27, 2013

2 A phase II trial of neoadjuvant nab-paclitaxel, carboplatin, and gemcitabine (ACAG) in patients with locally advanced carcinoma of the bladder Urology, May 24, 2013

3 5-azacytidine treatment for relapsed or refractory acute myeloid leukemia after intensive chemotherapy American Journal of Hematology, April 29, 2013

4 Current opinion on optimal treatment for colorectal cancer Expert Review of Anticancer Therapy, May 13, 2013    Review Article

5 The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy Supportive Care in Cancer, May 3, 2013

6 Health-related quality of life and symptoms in patients with myelofibrosis treated with ruxolitinib versus best available therapy British Journal of Haematology, May 17, 2013

7 Comparing cost-effectiveness analyses of denosumab versus zoledronic acid for the treatment of bone metastases Supportive Care in Cancer, May 3, 2013

8 Efficacy and cost of single-dose rasburicase in prevention and treatment of adult tumour lysis syndrome: a meta-analysis Journal of Clinical Pharmacy and Therapeutics, April 9, 2013    Evidence Based Medicine    Review Article

9 Feasibility and safety of dose-dense docetaxel after conventional epirubicin and cyclophosphamide as adjuvant treatment for early breast cancer patients The Breast, May 29, 2013

10 A randomized, phase II, three-arm study of two schedules of ixabepilone or paclitaxel plus bevacizumab as first-line therapy for metastatic breast cancer Breast Cancer Research and Treatment, May 7, 2013

11 Pain in outpatients treated for breast cancer: prevalence, pharmacological treatment, and impact on quality of life Cancer Nursing, May 10, 2013

12 Primary Granulocyte Colony-Stimulating Factor Prophylaxis During the First Two Cycles Only or Throughout All Chemotherapy Cycles in Patients With Breast Cancer at Risk for Febrile Neutropenia Journal of Clinical Oncology, May 2, 2013

13 Receipt of maintenance therapy is most predictive of survival in older acute lymphoblastic leukemia patients treated with intensive induction chemotherapy regimens American Journal of Hematology, May 3, 2013

14 Intrathecal administration of trastuzumab for the treatment of meningeal carcinomatosis in HER2-positive metastatic breast cancer: a systematic review and pooled analysis Breast Cancer Research and Treatment, April 17, 2013

15 Influence of CYP2D6-genotype on tamoxifen efficacy in advanced breast cancer Breast Cancer Research and Treatment, May 21, 2013

16 Mechanism of impaired glucose metabolism during nilotinib therapy in patients with chronic myelogenous leukemia Haematologica, May 29, 2013    Free full text

17 Long-term outcome with lenalidomide and dexamethasone therapy for newly diagnosed multiple myeloma Leukemia, May 29, 2013

18 High-Dose Cytarabine Consolidation With or Without Additional Amsacrine and Mitoxantrone in Acute Myeloid Leukemia: Results of the Prospective Randomized AML2003 Trial Journal of Clinical Oncology, May 1, 2013

19 Comparable outcome of stem cell transplant versus bortezomib-based consolidation in myeloma patients after major response to induction Hematology, May 21, 2013

20 Comparable outcome of stem cell transplant versus bortezomib-based consolidation in myeloma patients after major response to induction Hematology, May 28, 2013